Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions

Immunol Lett. 2012 Dec 17;148(2):151-62. doi: 10.1016/j.imlet.2012.09.004. Epub 2012 Sep 24.

Abstract

Psoriasis is a common chronic inflammatory skin disorder with dysregulation of miRNAs. The expression pattern of miR-146a and target gene IRAK1 in lesions and PBMCs of plaque psoriasis remains unclear. In our study, we found the expression of miR-146a was up-regulated both in lesions and PBMCs of psoriatic patients, and positively correlated with IL-17 expression, whereas the target gene IRAK1 expression was expressed differentially in lesions and peripheral blood. Inability of miR-146a inhibiting target gene IRAK1 may contribute to the persistent inflammation in lesions of psoriasis.

MeSH terms

  • Adult
  • Female
  • Gene Expression Regulation
  • Humans
  • Interferon-gamma / blood
  • Interleukin-1 Receptor-Associated Kinases / genetics
  • Interleukin-1 Receptor-Associated Kinases / metabolism*
  • Interleukin-17 / blood
  • Interleukin-17 / metabolism*
  • Male
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism*
  • Psoriasis / immunology
  • Psoriasis / metabolism*
  • Skin / metabolism
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Interleukin-17
  • MIRN146 microRNA, human
  • MicroRNAs
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • IRAK1 protein, human
  • Interleukin-1 Receptor-Associated Kinases